About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Prognosis of Melanoma Improved With Patient-Specific Immunotherapeutic Vaccine

by Reshma Anand on May 11, 2016 at 4:41 PM
Font : A-A+

Prognosis of Melanoma Improved With Patient-Specific Immunotherapeutic Vaccine

Malignant melanoma patients treated with personalized immunotherapeutic vaccines after resection of the hepatic tumor survived for at least 8.5 and 12 years.

The vaccines, designed to activate the immune system against the tumor, were derived from the patients' own dendritic cells loaded with proteins isolated from their tumors, as described in an article published in Cancer Biotherapy and Radiopharmaceuticals.

Advertisement


Robert O. Dillman, formerly Vice President Oncology, Caladrius Biosciences, Inc. and currently Chief Medical Officer, NeoStem Oncology (Irvine, CA) and Executive Medical and Scientific Director, Hoag Cancer Institute (Newport Beach, CA) discusses the typically poor prognosis for patients with melanoma of the eye or skin that spreads to the liver, and reports on the potential to achieve long-term survival without disease progression in a subset of patients using the eltrapuldencel-T vaccine.

One patient had no disease progression for more than 4.5 years, while the other patient survived and remained disease-free for more than 12 years. The article "Long-term Progression-free and Overall Survival in Two Melanoma Patients Treated with Patient-Specific Therapeutic Vaccine Eltrapuldencel-T After Resection of a Solitary Liver Metastasis," provides a detailed discussion of the composition and use of the vaccine and its effectiveness in these patients.
Advertisement

"These exciting results illustrate the potential for melanoma patient-specific therapeutic vaccines to enhance long-term survival and add to the progress being made on the immmunotherapy of melanom," says Co-Editor-in-Chief Donald J. Buchsbaum, Department of Radiation Oncology, Division of Radiation Biology, University of Alabama at Birmingham.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Skin Cancer Ultra-Violet Radiation Melanoma Vaccination for Children 

Most Popular on Medindia

Blood - Sugar Chart Vent Forte (Theophylline) Daily Calorie Requirements Post-Nasal Drip Pregnancy Confirmation Calculator Drug Interaction Checker Hearing Loss Calculator Find a Hospital Nutam (400mg) (Piracetam) Turmeric Powder - Health Benefits, Uses & Side Effects
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Prognosis of Melanoma Improved With Patient-Specific Immunotherapeutic Vaccine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests